UCBJY

UCB SA UNSP/ADR by UCB S.A. (UCBJY)

About UCB SA UNSP/ADR by UCB S.A. (UCBJY)

UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.

Details

Daily high
$144.80
Daily low
$143.43
Price at open
$143.67
52 Week High
$168.76
52 Week Low
$71.16
Market cap
55.1B
Dividend yield
0.55%
Volume
11,819
Avg. volume
40,758
P/E ratio
30.86

UCB SA UNSP/ADR by UCB S.A. News

Details

Daily high
$144.80
Daily low
$143.43
Price at open
$143.67
52 Week High
$168.76
52 Week Low
$71.16
Market cap
55.1B
Dividend yield
0.55%
Volume
11,819
Avg. volume
40,758
P/E ratio
30.86